Olopatadine HCl 0.1%; oph soln; contains benzalkonium chloride. <2yrs: consult physician. ≥2yrs: 1 drop in the affected eye(s) twice daily every 6–8hrs; max: twice per day.

The launched eye drops are compared to the active ingredient in Pataday Twice Daily Relief which have an estimated annual sales of $26.4 million in the latest 52 weeks’ period ending July 13, 2024.

Please provide your email address to receive an email when new articles are posted on . Several physicians who spoke with Healio Primary Care applauded the FDA’s decision to make Pataday Twice Daily ...

Diclofenac sodium topical gel and olopatadine HCl ophthalmic drops will soon be available over-the-counter (OTC) after the the Food and Drug Administration (FDA) switched the status of these products ...

Following a successful Rx-to-OTC switch last year, Alcon is wasting no time expanding its Pataday line of prescription-strength OTC products. The latest addition to the line is Pataday Once Daily ...

“Alcon is thrilled to bring another needed innovation to the millions of people in the U.S. who suffer from itchy allergy eyes,” said Sergio Duplan, Region President of North America at Alcon. “With ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

Glenmark has launched Olopatadine Hydrochloride Ophthalmic Solution, 0.1% (OTC). The company said its product compares to the active ingredient found in Pataday2 Twice Daily Relief. Pataday Twice ...

Now available in the U.S., Pataday® Once Daily Relief is the first and only eye drop to provide all day allergy itch relief without a prescription 1,2 Approximately 66 million Americans who suffer ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced Pataday Once Daily Relief Extra Strength (olopatadine ...